{"id":"NCT01187498","sponsor":"US Department of Veterans Affairs","briefTitle":"Behavioral Treatment of Overactive Bladder in Men","officialTitle":"Behavioral Treatment of Overactive Bladder in Men","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-01","primaryCompletion":"2009-10","completion":"2009-10","firstPosted":"2010-08-24","resultsPosted":"2014-05-20","lastUpdate":"2014-05-20"},"enrollment":143,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Overactive Bladder"],"interventions":[{"type":"BEHAVIORAL","name":"Behavioral training","otherNames":["Behavioral treatment"]},{"type":"DRUG","name":"Oxybutynin chloride, extended-release","otherNames":["Antimuscarinic medication"]}],"arms":[{"label":"Behavioral Training","type":"EXPERIMENTAL"},{"label":"Drug Therapy","type":"ACTIVE_COMPARATOR"}],"summary":"The primary purpose of this project is to evaluate the effectiveness of behavioral treatment compared to standard drug therapy for symptoms of OAB in male veterans.","primaryOutcome":{"measure":"24-hour Voiding Frequency","timeFrame":"post-treatment (week 8)","effectByArm":[{"arm":"Behavioral Training","deltaMin":9.1,"sd":2.5},{"arm":"Drug Therapy","deltaMin":9.5,"sd":2.4}],"pValues":[{"comp":"OG000 vs OG001","p":".001"}]},"eligibility":{"minAge":"19 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":16},"locations":{"siteCount":2,"countries":["United States"]},"refs":{"pmids":["22092152","37811598","23448285"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":73},"commonTop":[]}}